(1) Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Yugoslavia
Abstract:
Medical Oncology - First-line treatments of metastatic melanoma are usually decarbazine (DTIC) and/or α-interferon based, with response rates in the range of at most 20–30%. In this...